Close
0
You have no items in your order cart.
Search
Filters

Bravecto - 1000mg - Single

Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs.

Last up 12 weeks.

The following tablet strengths are:
Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg)
Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg)
Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg)
Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg)
Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).

This is a restricted product.
Please visit your Favourites List in My Account to purchase this item.

Availability: In stock
SKU: 118654
Product tags
Customers who bought this item also bought

Bravecto - 500mg - Single

118644
Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs.

Last up 12 weeks.

The following tablet strengths are:
Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg)
Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg)
Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg)
Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg)
Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).

Bravecto - 250mg - Single

118634
Chewable tablets containing fluralaner for the treatment and prevention of flea and tick infestations in dogs. Bravecto is a chewable tablet for dogs containing fluralaner. It is for the treatment and prevention of flea and tick infestations in dogs, for the treatment of demodicosis caused by Demodex canis and for the treatment of sarcoptic mange (Sarcoptes scabiei var. canis) infestation in dogs.

Last up 12 weeks.

The following tablet strengths are:
Bravecto 112.5 mg chewable tablets for very small dogs (2-4.5 kg)
Bravecto 250 mg chewable tablets for small dogs (>4.5-10 kg)
Bravecto 500 mg chewable tablets for medium-sized dogs (>10-20 kg)
Bravecto 1000 mg chewable tablets for large dogs (>20-40 kg)
Bravecto 1400 mg chewable tablets for very large dogs (>40-56 kg).

Bravecto Plus Spot On - Cat - 250mg

148324
Bravecto Plus spot-on solution for cats is a product for topical application containing fluralaner and moxidectin. It is for the treatment and prevention of flea and tick infestations and for the treatment of certain worms (roundworms (Toxocara cati), hookworms (Ancylostoma tubaeforme) and heartworm (Dirofilaria immitis) in cats.

For cats with, or at risk from, mixed parasitic infestations by ticks or fleas and ear mites, gastrointestinal nematodes or heartworm. The veterinary medicinal product is exclusively indicated when used against ticks or fleas and one or more of the other target parasites is indicated at the same time.

For the treatment of tick and flea infestations in cats providing immediate and persistent flea (Ctenocephalides felis) and tick (Ixodes ricinus) killing activity for 12 weeks. Fleas and ticks must attach to the host and commence feeding in order to be exposed to the active substance.
The product can be used as part of a treatment strategy for flea allergy dermatitis (FAD).
For the treatment of infestations with ear mites (Otodectes cynotis).
For the treatment of infections with intestinal roundworm (4th stage larvae, immature adults and adults of Toxocara cati) and hookworm (4th stage larvae, immature adults and adults of Ancylostoma tubaeforme).

When administered repeatedly at a 12-week interval, the product continuously prevents heartworm disease caused by Dirofilaria immitis.

Packaging Quantities
Bravecto 112.5 mg / 5.6mg spot-on solution for small cats (1.2 – 2.8 kg)
Bravecto 250 mg / 12.5 mg spot-on solution for medium-sized cats (>2.8 – 6.25 kg)
Bravecto 500 mg / 25 mg spot-on solution for large cats (>6.25 – 12.5 kg)

Heptavac P Plus - 100ml - IE

111790
Combined 7 in 1 Clostridial plus Pasteurella vaccine containing per ml: Clostridium perfringens beta toxoid : Clostridium perfringens epsilon toxoid ; Clostridium septicum: Clostridium tetani toxoid: Clostridium novyi toxoid ; Clostridium chauvoei cells and equivalent toxoid and formalin killed cells of the epidemiologically most important serotypes of Mannheimia haemolytica and Pasteurella trehalosi.

For the active immunisation of sheep as an aid in the control of lamb dysentery, pulpy kidney, struck, tetanus, braxy, blackleg, black disease and clostridial metritis caused by the above listed organisms. The vaccine may be used as an aid in the control of pneumonic pasteurellosis in sheep of all ages from a minimum age of 3 weeks and in the control of systemic pasteurellosis in weaned fattening and breeding sheep.

Dosage & Administration
• Sheep of all ages: 2 ml per injection by subcutaneous injection in the lateral side of the upper neck observing aseptic precautions.
• All breeding sheep not previously vaccinated with Heptavac P Plus must receive two injections, each of 2 ml, separated by an interval of 4-6 weeks.
• Thereafter they must receive booster injections at intervals of not more than 12 months.
• In adult breeding ewes these yearly booster injections should be given during the pre-lambing period, 4-6 weeks before lambing, as an aid in control of disease in their lambs.
• Ewes may be vaccinated during pregnancy as an aid in the control of lamb dysentery, pulpy kidney, tetanus and pasteurellosis in their lambs provided that the lambs receive sufficient immune colostrum during the first 1-2 days of life.
• On farms where the incidence of pasteurellosis is high, a supplementary booster injection using a Pasteurella vaccine may be required 2-3 weeks prior to expected seasonal outbreaks.
• Heptavac P Plus should not be used in lambs less than 3 weeks of age due to the possible immunological incompetence of the very young lamb and competition from any maternally derived colostral antibodies.
• Lambs being retained for fattening or subsequent breeding will require a full course of vaccination. At a minimum age of 3 weeks these lambs should receive two injections, each of 2.0 ml, separated by an interval of 4-6 weeks.R• It should be noted that Heptavac P Plus is the recommended vaccine for breeding stock since it provides optimal aid in the control of the predominant clostridial diseases in adult sheep by active immunisation and in young lambs by passive immunisation.